下一代测序识别甲状腺结节细针穿刺残留针冲洗液中的恶性预测基因突变
该研究分析24例甲状腺细针穿刺残留针冲洗液标本(恶性6例、不确定9例、良性9例),用下一代测序检测甲状腺癌常见基因突变和易位。23例获得可解读数据,4例恶性检出BRAF V600E,1例良性检出NRAS,不确定病例未检出突变;突变检测与最终手术诊断和临床结局相关。
要点
- 甲状腺FNA残留针冲洗液可用于分子诊断检测。
- BRAF V600E突变与甲状腺恶性手术诊断和临床结局相关。
- 不确定细胞学病例未检出突变,需扩大样本验证。
核心结论
- 甲状腺FNA残留针冲洗液是分子诊断检测的合适材料来源。
- 检出与甲状腺恶性相关的突变可预测最终手术诊断和临床结局。
- 对细胞学不确定的甲状腺结节行分子检测可避免额外FNA穿刺或额外侵入性操作。
研究设计与样本
- 在临床分子诊断实验室对24例甲状腺FNA残留针冲洗液标本行下一代测序。
- 标本按细胞学诊断分为恶性6例、不确定9例、良性9例。
- 测序检测甲状腺癌常见基因突变和易位,结果与手术诊断和临床结局关联。
主要发现
- 24例残留针冲洗液标本中23例获得可解读数据。
- 4例恶性病例检出BRAF V600E突变。
- 1例良性病例检出NRAS突变。
- 不确定诊断标本未检出突变。
临床怎么用
- 可利用甲状腺FNA残留针冲洗液进行分子检测,无需额外穿刺或专用培养基。
- 对细胞学不确定的结节,分子检测结果可辅助预测手术诊断和临床结局。
局限性
- 样本量小(24例),需更大样本研究确认临床效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: - Thyroid nodules have a prevalence of approximately 70% in adults. Fine-needle aspiration (FNA) is a minimally invasive, cost-effective, standard method to collect tissue from thyroid nodules for cytologic examination. However, approximately 15% of thyroid FNA specimens cannot be unambiguously diagnosed as benign or malignant. OBJECTIVE: - To investigate whether clinically actionable data can be obtained using next-generation sequencing of residual needle rinse material. DESIGN: - A total of 24 residual needle rinse specimens with malignant (n = 6), indeterminate (n = 9), or benign (n = 9) thyroid FNA diagnoses were analyzed in our clinical molecular diagnostics laboratory using next-generation sequencing assays designed to detect gene mutations and translocations that commonly occur in thyroid cancer. Results were correlated with surgical diagnoses and clinical outcomes. RESULTS: - Interpretable data were generated from 23 of 24 residual needle rinse specimens. Consistent with its well-known role in thyroid malignancy, BRAF V600E mutations were detected in 4 malignant cases. An NRAS mutation was detected in 1 benign case. No mutations were detected from specimens with indeterminate diagnoses. CONCLUSIONS: - Our data demonstrate that residual thyroid FNA needle rinses are an adequate source of material for molecular diagnostic testing. Importantly, detection of a mutation implicated in thyroid malignancy was predictive of the final surgical diagnosis and clinical outcome. Our strategy to triage thyroid nodules with indeterminate cytology with molecular testing eliminates the need to perform additional FNA passes into dedicated media or to schedule additional invasive procedures. Further investigation with a larger sample size to confirm the clinical utility of our proposed strategy is underway.
引用
- Fuller MY, Mody D, Hull A, et al. Next-Generation Sequencing Identifies Gene Mutations That Are Predictive of Malignancy in Residual Needle Rinses Collected From Fine-Needle Aspirations of Thyroid Nodules. Arch Pathol Lab Med. 2017. PMID: 28537807. doi:10.5858/arpa.2017-0136-OA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。